WithdrawnNCT01075126
Safety Study of Depakote Versus Lithium in African Americans With Bipolarity
Medication studyAges 18–60United States
Understand this study
Who could participate?
Listed age limits: 18 years to 60 years.
- Listed locations
- Washington D.C.See all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateDecember 2006
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 50
- Sponsor
- Lawson, William B., M.D., PhD, DFAPA
- Sponsor type
- Individual investigator
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 60 Years
- Official registry ID
- NCT01075126
- Official title
Show the full official title
Depakote Vs. Lithium in African Americans With Bipolar Disorder
Recruitment & locations
WithdrawnThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Washington D.C.
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Lawson, William B., M.D., PhD, DFAPA.
Does this study involve medication?
Yes. The study involves medication, including Depakote and lithium.
Who can participate?
Listed age limits: 18 years to 60 years.
Is this study still recruiting?
The registry lists this study as withdrawn.
